Adnan Tufail

Biography

 Dr. Tufail is one of the leading ophthalmic surgeons in the UK and is the clinical and research lead at Moorfields Eye Hospital in London for age-related macular degeneration. He has worked as a consultant at Moorfields Eye Hospital since 2002 and is an Honorary Senior Lecturer at University College London Institute of Ophthalmology. Dr. Tufail’s main subspecialty interest is medical retina disorders. His current area of research interest includes novel therapies for dry AMD, choroidal neovascularization and diabetic retinopathy. Dr. Tufail has published more than 80 peer-reviewed journal articles. Most notably, he was a co-principal investigator in the seminal ABC Trial examining bevacizumab for neovascular age related macular degeneration. The ABC Trial became a cornerstone for anti-VEGF treatment protocols for wet-AMD therapy within the National Health Service (NHS).

Research Interest

 anti-VEGF treatment protocols